Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by P. Carde
Prognostic Value of Immunohistochemical Markers in Stage Iii/Iv Classical Hodgkin Lymphoma Treated Frontline in the Lysa Eortc 20012 Randomized Protocol
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Related publications
Prognostic Significance of New Immunohistochemical Markers in Refractory Classical Hodgkin Lymphoma: A Study of 59 Cases
PLoS ONE
Multidisciplinary
Bone Involvement: A Poor Prognostic Factor in Stage IV Hodgkin Lymphoma
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
The Glasgow Prognostic Score at Diagnosis Is an Independent Predictor of Survival in Advanced Stage Classical Hodgkin Lymphoma
British Journal of Haematology
Hematology
Prognostic Value of Pre-Transplant Pet/Ct in Hodgkin Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Outcome and Treatment of Relapsing Early Pet Negative Patients Included in the Eortc/Lysa/Fil H10 Trial on Stages I/Ii Hodgkin Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Pre-Treatment Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio Are Prognostic of Progression in Early Stage Classical Hodgkin Lymphoma
British Journal of Haematology
Hematology
EBV-Positive Plasmablastic Lymphoma Mimicking Reactive Lymphadenopathy Versus Recurrent Hodgkin Lymphoma Following Chemotherapy for Stage II Classical Hodgkin Lymphoma
Journal of Tumour Research & Reports
Outcome of Children and Adolescents With Lymphoblastic Lymphoma Treated With the Eortc 58951 Protocol
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Preliminary Results of a Quality Control Study on Involved Node Radiotherapy in the Eortc/Lysa/Fil H10 Trial on Stages I/Ii Hodgkin Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
